581301-U
Ascentis® C18 (3 µm) HPLC Columns
L × I.D. 10 cm × 2.1 mm, HPLC Column
Sinônimo(s):
Ascentis RP18 HPLC Column
About This Item
Produtos recomendados
Nome do produto
Ascentis® C18 HPLC Column, 3 μm particle size, L × I.D. 10 cm × 2.1 mm
Materiais
stainless steel column
Nível de qualidade
Agency
suitable for USP L1 (Similar to Phenomenex Luna C18)
linha de produto
Ascentis®
Características
endcapped
fabricante/nome comercial
Ascentis®
embalagem
1 ea of
Extensão da rotulagem
25% Carbon loading
Parâmetros
≤70 °C temp. range
400 bar pressure (5801 psi)
técnica(s)
HPLC: suitable
LC/MS: suitable
C × D.I.
10 cm × 2.1 mm
área da superfície
450 m2/g
cobertura de superfície
3.7 μmol/m2
Impurezas
<5 ppm metals
Matriz
fully porous particle
silica gel high purity, spherical
Grupo ativo da matriz
C18 (octadecyl) phase
tamanho de partícula
3 μm
tamanho de poro
100 Å
Faixa de pH operacional
2-8
aplicação(ões)
food and beverages
técnica de separação
reversed phase
Procurando produtos similares? Visita Guia de comparação de produtos
Categorias relacionadas
Descrição geral
Ascentis C18 is an extremely stable and reliable first choice HPLC column that gives symmetric peak shape and excellent retention even for difficult compounds.
Aplicação
- Identification of recombinant human insulin and biosynthetic insulin analogues by multiplexed targeted unlabeled mass spectrometry of proteotypic tryptic peptides.: This study employs the Ascentis® C18 HPLC column for the separation of proteotypic tryptic peptides, allowing the identification of human insulin and biosynthetic insulin analogues through multiplexed targeted unlabeled mass spectrometry. The method demonstrated high specificity and sensitivity, enhancing the accuracy of insulin analysis in pharmaceutical research (Qasem et al., 2019).
- Development and validation of a novel stability-indicating HPLC method for the simultaneous assay of betamethasone-17-valerate, fusidic acid, potassium sorbate, methylparaben, and propylparaben in a topical cream preparation.: Utilizing the Ascentis® C18 HPLC column, this research presents a novel stability-indicating method for the simultaneous assay of multiple compounds in a topical cream. The validated method offers robust stability assessment, critical for ensuring the quality and efficacy of pharmaceutical formulations (Byrne et al., 2014).
- HPLC-DAD and HPLC-ESI-MS/MS methods for metabolite profiling of propolis extracts.: This paper describes the use of the Ascentis® C18 HPLC column in HPLC-DAD and HPLC-ESI-MS/MS methods to profile metabolites in propolis extracts. The column′s performance in separating complex mixtures highlights its utility in natural product research and quality control (Pellati et al., 2011).
- Practical comparison of 2.7 microm fused-core silica particles and porous sub-2 microm particles for fast separations in pharmaceutical process development.: This study compares the performance of the Ascentis® C18 HPLC column with other chromatographic columns for fast separations in pharmaceutical process development. The Ascentis® column provided superior separation efficiency and speed, making it advantageous for high-throughput pharmaceutical analysis (Abrahim et al., 2010).
Características e benefícios
- Excellent retention
- Symmetric peak shape
- High reproducibility
- Complete LC-MS compatibility
Informações legais
Aplicação
produto relacionado
Código de classe de armazenamento
11 - Combustible Solids
Classe de risco de água (WGK)
WGK 3
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Escolha uma das versões mais recentes:
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Chromatograms
application for SPE, application for LC-MSActive Filters
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica